HEADER TRANSFERASE/TRANSFERASE INHIBITOR 31-MAY-18 6DKW TITLE CRYSTAL STRUCTURE OF TRK-A IN COMPLEX WITH THE PAN-TRK KINASE TITLE 2 INHIBITOR, COMPOUND 3. COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.10.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NTRK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR TYROSINE KINASE, TRANSFERASE, PAN-TRK KINASE, TREATMENT FOR KEYWDS 2 PAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,D.BROWN REVDAT 3 13-MAR-24 6DKW 1 REMARK REVDAT 2 15-AUG-18 6DKW 1 JRNL REVDAT 1 11-JUL-18 6DKW 0 JRNL AUTH S.K.BAGAL,M.ANDREWS,B.M.BECHLE,J.BIAN,J.BILSLAND, JRNL AUTH 2 D.C.BLAKEMORE,J.F.BRAGANZA,P.J.BUNGAY,M.S.CORBETT, JRNL AUTH 3 C.N.CRONIN,J.J.CUI,R.DIAS,N.J.FLANAGAN,S.E.GREASLEY, JRNL AUTH 4 R.GRIMLEY,K.JAMES,E.JOHNSON,L.KITCHING,M.L.KRAUS,I.MCALPINE, JRNL AUTH 5 A.NAGATA,S.NINKOVIC,K.OMOTO,S.SCALES,S.E.SKERRATT,J.SUN, JRNL AUTH 6 M.TRAN-DUBE,G.J.WALDRON,F.WANG,J.S.WARMUS JRNL TITL DISCOVERY OF POTENT, SELECTIVE, AND PERIPHERALLY RESTRICTED JRNL TITL 2 PAN-TRK KINASE INHIBITORS FOR THE TREATMENT OF PAIN. JRNL REF J. MED. CHEM. V. 61 6779 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29944371 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00633 REMARK 2 REMARK 2 RESOLUTION. 2.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 18268 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 931 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.91 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.05 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2826 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2777 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2681 REMARK 3 BIN R VALUE (WORKING SET) : 0.2757 REMARK 3 BIN FREE R VALUE : 0.3142 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.13 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 145 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4433 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 73 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 93.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 95.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -19.74190 REMARK 3 B22 (A**2) : -19.74190 REMARK 3 B33 (A**2) : 39.48380 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.470 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.379 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.888 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.852 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4705 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6418 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1627 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 99 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 753 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4705 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 553 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5297 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.03 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.98 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DKW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1000234832. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-NOV-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18303 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.910 REMARK 200 RESOLUTION RANGE LOW (A) : 81.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 9.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 18.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 10.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.60900 REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NOT AVAILABLE, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 106.18000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 53.09000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 53.09000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 106.18000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 617 REMARK 465 ALA A 618 REMARK 465 PRO A 619 REMARK 465 MET A 671 REMARK 465 SER A 672 REMARK 465 ARG A 673 REMARK 465 ASP A 674 REMARK 465 ILE A 675 REMARK 465 TYR A 676 REMARK 465 SER A 677 REMARK 465 THR A 678 REMARK 465 ASP A 679 REMARK 465 TYR A 680 REMARK 465 TYR A 681 REMARK 465 ARG A 682 REMARK 465 VAL A 683 REMARK 465 GLY A 684 REMARK 465 GLY A 685 REMARK 465 ARG A 686 REMARK 465 THR A 687 REMARK 465 MET A 688 REMARK 465 VAL A 794 REMARK 465 LEU A 795 REMARK 465 GLY A 796 REMARK 465 MET B 489 REMARK 465 HIS B 490 REMARK 465 HIS B 491 REMARK 465 HIS B 492 REMARK 465 HIS B 493 REMARK 465 HIS B 494 REMARK 465 HIS B 495 REMARK 465 GLY B 519 REMARK 465 ALA B 520 REMARK 465 PHE B 521 REMARK 465 LEU B 610 REMARK 465 LEU B 611 REMARK 465 ALA B 612 REMARK 465 GLY B 613 REMARK 465 GLY B 614 REMARK 465 GLU B 615 REMARK 465 ASP B 616 REMARK 465 VAL B 617 REMARK 465 ALA B 618 REMARK 465 PRO B 619 REMARK 465 MET B 671 REMARK 465 SER B 672 REMARK 465 ARG B 673 REMARK 465 ASP B 674 REMARK 465 ILE B 675 REMARK 465 TYR B 676 REMARK 465 SER B 677 REMARK 465 THR B 678 REMARK 465 ASP B 679 REMARK 465 TYR B 680 REMARK 465 TYR B 681 REMARK 465 ARG B 682 REMARK 465 VAL B 683 REMARK 465 GLY B 684 REMARK 465 GLY B 685 REMARK 465 ARG B 686 REMARK 465 VAL B 794 REMARK 465 LEU B 795 REMARK 465 GLY B 796 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 615 CG CD OE1 OE2 REMARK 470 LYS B 609 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 613 N - CA - C ANGL. DEV. = -19.6 DEGREES REMARK 500 ASP A 616 C - N - CA ANGL. DEV. = 16.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 513 -62.07 -96.68 REMARK 500 PHE A 521 -106.69 59.76 REMARK 500 LYS A 523 145.75 81.99 REMARK 500 ALA A 549 -150.18 -84.11 REMARK 500 SER A 550 129.45 76.56 REMARK 500 GLU A 581 97.70 -60.22 REMARK 500 ARG A 649 -13.91 72.43 REMARK 500 GLN A 660 96.11 -36.39 REMARK 500 ASP A 668 118.82 -163.87 REMARK 500 LYS B 513 -62.41 -96.71 REMARK 500 LEU B 516 -67.11 -99.78 REMARK 500 SER B 550 105.05 -53.85 REMARK 500 GLU B 551 -32.45 -26.35 REMARK 500 GLU B 581 96.34 -68.24 REMARK 500 ASP B 607 -18.05 71.42 REMARK 500 ALA B 608 104.37 -54.65 REMARK 500 ARG B 649 -19.15 77.06 REMARK 500 GLN B 786 -92.86 -70.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 929 DISTANCE = 5.94 ANGSTROMS REMARK 525 HOH A 930 DISTANCE = 7.35 ANGSTROMS REMARK 525 HOH A 931 DISTANCE = 7.98 ANGSTROMS REMARK 525 HOH A 932 DISTANCE = 8.13 ANGSTROMS REMARK 525 HOH A 933 DISTANCE = 8.14 ANGSTROMS REMARK 525 HOH A 934 DISTANCE = 8.54 ANGSTROMS REMARK 525 HOH A 935 DISTANCE = 9.03 ANGSTROMS REMARK 525 HOH B 931 DISTANCE = 5.85 ANGSTROMS REMARK 525 HOH B 932 DISTANCE = 6.20 ANGSTROMS REMARK 525 HOH B 933 DISTANCE = 6.34 ANGSTROMS REMARK 525 HOH B 934 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH B 935 DISTANCE = 6.87 ANGSTROMS REMARK 525 HOH B 936 DISTANCE = 7.00 ANGSTROMS REMARK 525 HOH B 937 DISTANCE = 7.14 ANGSTROMS REMARK 525 HOH B 938 DISTANCE = 7.69 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GXA A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GXA B 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6DKB RELATED DB: PDB REMARK 900 RELATED ID: 6DKG RELATED DB: PDB REMARK 900 RELATED ID: 6DKI RELATED DB: PDB DBREF 6DKW A 502 796 UNP J3KP20 J3KP20_HUMAN 499 793 DBREF 6DKW B 502 796 UNP J3KP20 J3KP20_HUMAN 499 793 SEQADV 6DKW MET A 489 UNP J3KP20 INITIATING METHIONINE SEQADV 6DKW HIS A 490 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS A 491 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS A 492 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS A 493 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS A 494 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS A 495 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW LEU A 496 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW VAL A 497 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW PRO A 498 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW ARG A 499 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW GLY A 500 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW SER A 501 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW MET B 489 UNP J3KP20 INITIATING METHIONINE SEQADV 6DKW HIS B 490 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS B 491 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS B 492 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS B 493 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS B 494 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW HIS B 495 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW LEU B 496 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW VAL B 497 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW PRO B 498 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW ARG B 499 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW GLY B 500 UNP J3KP20 EXPRESSION TAG SEQADV 6DKW SER B 501 UNP J3KP20 EXPRESSION TAG SEQRES 1 A 308 MET HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG GLY SER SEQRES 2 A 308 VAL HIS HIS ILE LYS ARG ARG ASP ILE VAL LEU LYS TRP SEQRES 3 A 308 GLU LEU GLY GLU GLY ALA PHE GLY LYS VAL PHE LEU ALA SEQRES 4 A 308 GLU CYS HIS ASN LEU LEU PRO GLU GLN ASP LYS MET LEU SEQRES 5 A 308 VAL ALA VAL LYS ALA LEU LYS GLU ALA SER GLU SER ALA SEQRES 6 A 308 ARG GLN ASP PHE GLN ARG GLU ALA GLU LEU LEU THR MET SEQRES 7 A 308 LEU GLN HIS GLN HIS ILE VAL ARG PHE PHE GLY VAL CYS SEQRES 8 A 308 THR GLU GLY ARG PRO LEU LEU MET VAL PHE GLU TYR MET SEQRES 9 A 308 ARG HIS GLY ASP LEU ASN ARG PHE LEU ARG SER HIS GLY SEQRES 10 A 308 PRO ASP ALA LYS LEU LEU ALA GLY GLY GLU ASP VAL ALA SEQRES 11 A 308 PRO GLY PRO LEU GLY LEU GLY GLN LEU LEU ALA VAL ALA SEQRES 12 A 308 SER GLN VAL ALA ALA GLY MET VAL TYR LEU ALA GLY LEU SEQRES 13 A 308 HIS PHE VAL HIS ARG ASP LEU ALA THR ARG ASN CYS LEU SEQRES 14 A 308 VAL GLY GLN GLY LEU VAL VAL LYS ILE GLY ASP PHE GLY SEQRES 15 A 308 MET SER ARG ASP ILE TYR SER THR ASP TYR TYR ARG VAL SEQRES 16 A 308 GLY GLY ARG THR MET LEU PRO ILE ARG TRP MET PRO PRO SEQRES 17 A 308 GLU SER ILE LEU TYR ARG LYS PHE THR THR GLU SER ASP SEQRES 18 A 308 VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE PHE THR SEQRES 19 A 308 TYR GLY LYS GLN PRO TRP TYR GLN LEU SER ASN THR GLU SEQRES 20 A 308 ALA ILE ASP CYS ILE THR GLN GLY ARG GLU LEU GLU ARG SEQRES 21 A 308 PRO ARG ALA CYS PRO PRO GLU VAL TYR ALA ILE MET ARG SEQRES 22 A 308 GLY CYS TRP GLN ARG GLU PRO GLN GLN ARG HIS SER ILE SEQRES 23 A 308 LYS ASP VAL HIS ALA ARG LEU GLN ALA LEU ALA GLN ALA SEQRES 24 A 308 PRO PRO VAL TYR LEU ASP VAL LEU GLY SEQRES 1 B 308 MET HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG GLY SER SEQRES 2 B 308 VAL HIS HIS ILE LYS ARG ARG ASP ILE VAL LEU LYS TRP SEQRES 3 B 308 GLU LEU GLY GLU GLY ALA PHE GLY LYS VAL PHE LEU ALA SEQRES 4 B 308 GLU CYS HIS ASN LEU LEU PRO GLU GLN ASP LYS MET LEU SEQRES 5 B 308 VAL ALA VAL LYS ALA LEU LYS GLU ALA SER GLU SER ALA SEQRES 6 B 308 ARG GLN ASP PHE GLN ARG GLU ALA GLU LEU LEU THR MET SEQRES 7 B 308 LEU GLN HIS GLN HIS ILE VAL ARG PHE PHE GLY VAL CYS SEQRES 8 B 308 THR GLU GLY ARG PRO LEU LEU MET VAL PHE GLU TYR MET SEQRES 9 B 308 ARG HIS GLY ASP LEU ASN ARG PHE LEU ARG SER HIS GLY SEQRES 10 B 308 PRO ASP ALA LYS LEU LEU ALA GLY GLY GLU ASP VAL ALA SEQRES 11 B 308 PRO GLY PRO LEU GLY LEU GLY GLN LEU LEU ALA VAL ALA SEQRES 12 B 308 SER GLN VAL ALA ALA GLY MET VAL TYR LEU ALA GLY LEU SEQRES 13 B 308 HIS PHE VAL HIS ARG ASP LEU ALA THR ARG ASN CYS LEU SEQRES 14 B 308 VAL GLY GLN GLY LEU VAL VAL LYS ILE GLY ASP PHE GLY SEQRES 15 B 308 MET SER ARG ASP ILE TYR SER THR ASP TYR TYR ARG VAL SEQRES 16 B 308 GLY GLY ARG THR MET LEU PRO ILE ARG TRP MET PRO PRO SEQRES 17 B 308 GLU SER ILE LEU TYR ARG LYS PHE THR THR GLU SER ASP SEQRES 18 B 308 VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE PHE THR SEQRES 19 B 308 TYR GLY LYS GLN PRO TRP TYR GLN LEU SER ASN THR GLU SEQRES 20 B 308 ALA ILE ASP CYS ILE THR GLN GLY ARG GLU LEU GLU ARG SEQRES 21 B 308 PRO ARG ALA CYS PRO PRO GLU VAL TYR ALA ILE MET ARG SEQRES 22 B 308 GLY CYS TRP GLN ARG GLU PRO GLN GLN ARG HIS SER ILE SEQRES 23 B 308 LYS ASP VAL HIS ALA ARG LEU GLN ALA LEU ALA GLN ALA SEQRES 24 B 308 PRO PRO VAL TYR LEU ASP VAL LEU GLY HET GXA A 801 61 HET GXA B 801 61 HETNAM GXA 5-(1-METHYL-1H-IMIDAZOL-4-YL)-2-[(1-{[4- HETNAM 2 GXA (TRIFLUOROMETHOXY)PHENYL]ACETYL}PIPERIDIN-4-YL) HETNAM 3 GXA OXY]BENZAMIDE FORMUL 3 GXA 2(C25 H25 F3 N4 O4) FORMUL 5 HOH *73(H2 O) HELIX 1 AA1 LYS A 506 ARG A 508 5 3 HELIX 2 AA2 ALA A 549 LEU A 567 1 19 HELIX 3 AA3 ASP A 596 HIS A 604 1 9 HELIX 4 AA4 ASP A 607 ALA A 612 1 6 HELIX 5 AA5 GLY A 623 LEU A 644 1 22 HELIX 6 AA6 ALA A 652 ARG A 654 5 3 HELIX 7 AA7 PRO A 690 MET A 694 5 5 HELIX 8 AA8 PRO A 695 ARG A 702 1 8 HELIX 9 AA9 THR A 705 THR A 722 1 18 HELIX 10 AB1 SER A 732 GLY A 743 1 12 HELIX 11 AB2 PRO A 753 TRP A 764 1 12 HELIX 12 AB3 GLU A 767 ARG A 771 5 5 HELIX 13 AB4 SER A 773 ALA A 787 1 15 HELIX 14 AB5 LYS B 506 ARG B 508 5 3 HELIX 15 AB6 SER B 550 THR B 565 1 16 HELIX 16 AB7 ASP B 596 HIS B 604 1 9 HELIX 17 AB8 GLY B 623 LEU B 644 1 22 HELIX 18 AB9 ALA B 652 ARG B 654 5 3 HELIX 19 AC1 PRO B 690 MET B 694 5 5 HELIX 20 AC2 PRO B 695 ARG B 702 1 8 HELIX 21 AC3 THR B 705 THR B 722 1 18 HELIX 22 AC4 SER B 732 GLY B 743 1 12 HELIX 23 AC5 PRO B 753 TRP B 764 1 12 HELIX 24 AC6 GLU B 767 ARG B 771 5 5 HELIX 25 AC7 SER B 773 ALA B 787 1 15 SHEET 1 AA1 5 ILE A 510 GLU A 515 0 SHEET 2 AA1 5 VAL A 524 HIS A 530 -1 O LEU A 526 N LYS A 513 SHEET 3 AA1 5 LYS A 538 ALA A 545 -1 O MET A 539 N CYS A 529 SHEET 4 AA1 5 LEU A 586 GLU A 590 -1 O PHE A 589 N ALA A 542 SHEET 5 AA1 5 PHE A 575 CYS A 579 -1 N PHE A 576 O VAL A 588 SHEET 1 AA2 2 CYS A 656 GLY A 659 0 SHEET 2 AA2 2 VAL A 663 ILE A 666 -1 O LYS A 665 N LEU A 657 SHEET 1 AA3 5 ILE B 510 GLU B 515 0 SHEET 2 AA3 5 VAL B 524 HIS B 530 -1 O LEU B 526 N TRP B 514 SHEET 3 AA3 5 LYS B 538 ALA B 545 -1 O MET B 539 N CYS B 529 SHEET 4 AA3 5 LEU B 586 GLU B 590 -1 O PHE B 589 N ALA B 542 SHEET 5 AA3 5 PHE B 575 CYS B 579 -1 N GLY B 577 O VAL B 588 SHEET 1 AA4 2 CYS B 656 GLY B 659 0 SHEET 2 AA4 2 VAL B 663 ILE B 666 -1 O LYS B 665 N LEU B 657 CISPEP 1 ARG A 583 PRO A 584 0 5.17 CISPEP 2 ARG B 583 PRO B 584 0 1.30 SITE 1 AC1 19 VAL A 524 ALA A 542 LEU A 564 LEU A 567 SITE 2 AC1 19 ILE A 572 VAL A 573 PHE A 589 GLU A 590 SITE 3 AC1 19 TYR A 591 MET A 592 ARG A 593 GLY A 595 SITE 4 AC1 19 LEU A 641 PHE A 646 HIS A 648 LEU A 657 SITE 5 AC1 19 ILE A 666 GLY A 667 ASP A 668 SITE 1 AC2 16 LEU B 516 ALA B 542 LEU B 564 LEU B 567 SITE 2 AC2 16 VAL B 573 PHE B 589 GLU B 590 TYR B 591 SITE 3 AC2 16 MET B 592 ARG B 593 GLY B 595 LEU B 641 SITE 4 AC2 16 HIS B 648 ILE B 666 GLY B 667 ASP B 668 CRYST1 93.980 93.980 159.270 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010641 0.006143 0.000000 0.00000 SCALE2 0.000000 0.012287 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006279 0.00000